Quality of life and response of negative symptoms in schizophrenia to haloperidol and the atypical antipsychotic remoxipride

Journal article

Peer reviewed

A. G Awad, Y. D Lapierre, C Angus and A Rylander

Journal of psychiatry & neuroscience, Vol.22(4), pp.244-248

01/07/1997

PMID: 9262046

Abstract

Biological and medical sciences

Medical sciences

Neuropharmacology

Pharmacology. Drug treatments

Psycholeptics: tranquillizer, neuroleptic

Psychology. Psychoanalysis. Psychiatry

Psychopharmacology

1 Record Views

Title: Quality of life and response of negative symptoms in schizophrenia to haloperidol and the atypical antipsychotic remoxipride
Creators - without role: A. G Awad
Y. D Lapierre
C Angus - Medical Department, Astra Pharma Inc, Mississauga, Ontario, Canada
A Rylander - Astra Arcus, Sodertalje, Sweden
Publication Details: Journal of psychiatry & neuroscience, Vol.22(4), pp.244-248
Publisher: Canadian Medical Association
Identifiers: 9923968808331
Academic Unit: King Khalid University
Language: English
Resource Type: Journal article